Stress test your approach to Sabra Health Care REIT by comparing it with a curated group of landlords focused on tenant quality and resilient balance sheets through our list of solid balance sheet and fundamentals (23 results).
To own Sabra Health Care REIT, you really have to believe the managed senior housing push and portfolio recycling can turn into steady, repeatable cash flows even as the sector debates tenant credit risk again. The short term swing factor is whether Sabra’s operators keep paying on time and maintain occupancy while management is still re tenanting assets like the Avamere portfolio.
The biggest near term risk is strain on retained cash. Sabra is funding a large SHOP focused pipeline while dealing with items like the US$102.4 million loan loss reserve and interest costs that are not well covered by earnings. If tenant issues similar to HSA spread into Sabra’s base, that pressure would only increase.
Without a fresh headline tied directly to this Medical Properties Trust news, the most relevant reference point is Sabra’s ongoing shift toward SHOP, with over 95% of more than US$1b of active opportunities tied to managed senior housing. For this model to work, tenant performance needs to hold up so those properties keep supporting occupancy, RevPOR and cash NOI.
That same SHOP pivot also intersects with the rent collection story. Managed senior housing puts Sabra closer to day to day operations, which can help monitor trends in real time but also exposes the REIT to higher operating complexity and costs. For you, the key watch items around the next print are tenant level health, any new loan reserves and how much balance sheet flexibility Sabra retains for further investment.
Sabra Health Care REIT’s current analyst storyline points to about US$1.2b of revenue and US$243.7 million of earnings by 2029, built on forecast revenue growth of 10.1% each year and an earnings increase of roughly US$178 million from today’s US$65.4 million level.
Uncover why Sabra Health Care REIT's fair value indicates a 16% potential upside to its current price, which could narrow quickly.
The Simply Wall St Community provides two fair value views for Sabra Health Care REIT, and they are far apart, ranging from US$22.79 to US$56.67 per share. That spread leaves considerable room for different conclusions, especially with portfolio reshuffling and tenant transitions that could either support earnings resilience or strain cash and rent coverage. Readers may wish to compare several of these perspectives before deciding how much tenant risk they are comfortable holding.
Explore another Sabra Health Care REIT fair value estimate, including one that suggests it could be worth just $22.79.
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
If you want to pressure test your view on Sabra Health Care REIT against other opportunities, it can help to scan a wider field of potential holdings with different risk and income profiles.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com